Medical device startup NeuroWave Systems Inc. has reached a deal in which CareFusion (NYSE: CFN) will distribute NeuroWave’s brain-activity monitoring system in Germany and Scandinavia. It’s an important step for Cleveland Heights, Ohio-based NeuroWave, which in June received European regulatory clearance to begin selling its NeuroSense brain monitor for assessing anesthesia levels.

A federal judge in California dealt a setback to CareFusion Corp. (NYSE:CFN) in its anti-trust and patent infringement lawsuit against Medtronic Inc. (NYSE:MDT), tossing the anti-trust claims but giving CareFusion an out.Judge Lucy Koh of the U.S. District Court for Northern California ruled that CareFusion failed to prove that Medtronic [...]

Pharmaceutical and medical products supplier Cardinal Health Inc. has sold its remaining stake in spinoff medical technology company CareFusion for $706 million.

About 800,000 American per year are medical tourists–that is they leave the cozy confines of the good ol’ US of A to seek medical treatment in cheaper locales. But where’s the intrepid medical tourist to go, and for what procedures?

CareFusion Corp. (NYSE:CFN) posted bottom-line declines for both the fourth quarter and its first year as a public company, prompting the medical device maker to slash its workforce by 4.7 percent despite positive top-line growth.San Diego-based CareFusion reported profits of $52 million, or 23 cents per diluted share, on sales of [...]

The U.S. Food & Drug Administration said it is requiring nine medical device companies to conduct postmarket analysis on a connection between needless connectors and higher rates of blood stream infections.In a notice posted on the Centers for Devices and Radiological Health web site, officials said that the agency is “aware of [...]

Medical technology company CareFusion Corp.–spun out by Ohio’s Cardinal Health late last summer–has sued Medtronic Inc., accusing the Fridley, Minn., medical device giant of monopolistic and predatory practices in the market for products to treat compression fractures of spinal vertebrae.“CareFusion has been the victim of a scheme by the defendants to keep competitors out of [...]

Boston Scientific estimated this issue, plus an advisory related to a small number of defibrillator issues that sparked product changes, could hurt this year’s heart-rhythm business sales by up to $100 million. The whole business, which includes pacemakers and defibrillators, posted 2009 sales of $2.56 billion.

Strong fourth-quarter sales for surgical-robot maker Intuitive Surgical Inc. and sales improvements for General Electric Co.’s Healthcare unit on Friday suggest U.S. hospitals may be ready to spend again on expensive capital equipment.

The University of Cincinnati College of Medicine has launched an early stage cancer drug development program and phase-1 clinical trials unit for patients who have solid tumors that have resisted cancer therapies.